Get the Stockscreener App
2.49
0.80%
-0.02
Aerovate Therapeutics Inc stock is traded at $2.49, with a volume of 94,583.
It is down -0.80% in the last 24 hours and up +2.89% over the past month.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
See More
Previous Close:
$2.51
Open:
$2.47
24h Volume:
94,583
Relative Volume:
0.70
Market Cap:
$72.17M
Revenue:
-
Net Income/Loss:
$-75.52M
P/E Ratio:
-0.8646
EPS:
-2.88
Net Cash Flow:
$-56.92M
1W Performance:
-1.58%
1M Performance:
+2.89%
6M Performance:
+21.46%
1Y Performance:
-91.44%
1-Day Range:
$2.45
$2.575
1-Week Range:
$2.45
$2.575
52-Week Range:
$1.25
$28.70
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
Name
Aerovate Therapeutics Inc
Sector
Industry
Phone
617-443-2400
Address
930 WINTER STREET, WALTHAM
Compare AVTE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVTE
Aerovate Therapeutics Inc
|
2.49 | 72.17M | 0 | -75.52M | -56.92M | -2.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-18-24 | Downgrade | TD Cowen | Buy → Hold |
| Jun-18-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-17-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-17-24 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-25-24 | Resumed | Jefferies | Buy |
| Dec-08-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Dec-06-22 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-19-22 | Resumed | Wedbush | Outperform |
| Aug-16-22 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-11-22 | Initiated | BTIG Research | Buy |
| Jul-26-21 | Initiated | Cowen | Outperform |
| Jul-26-21 | Initiated | Evercore ISI | Outperform |
| Jul-26-21 | Initiated | Jefferies | Buy |
| Jul-26-21 | Initiated | Wedbush | Outperform |
View All
Aerovate Therapeutics Inc Stock (AVTE) Latest News
36,897 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Acquired by Corient Private Wealth LLC - Defense World
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AMPY, HEES, AVTE, TGI to Act Now - GlobeNewswire Inc.
Aerovate Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aerovate Therapeutics Inc. (AVTE) reports earnings - Quartz
Aerovate Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, PTMN, AVTE on Behalf of Shareholders - The Malaysian Reserve
Aerovate Therapeutics (AVTE) Expected to Announce Quarterly Earnings on Monday - Defense World
FY2029 Earnings Estimate for AVTE Issued By Wedbush - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders - ACCESS Newswire
FY2029 Earnings Forecast for AVTE Issued By Wedbush - Defense World
In Another Blow to Delaware's Hegemony Another Company Proposes Reincorporation in Nevada - The National Law Review
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCCNE, LGTY, AVTE, PLYA - Longview News-Journal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders - Stockhouse Publishing
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Increase in Short Interest - MarketBeat
Ready to Jump After Recent Trade: Aerovate Therapeutics Inc (AVTE) - SETE News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders - EIN News
Deltec Asset Management LLC Invests $514,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Growth in Short Interest - MarketBeat
Barclays PLC Raises Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MHLD, IPG, AVTE on Behalf of Shareholders - GlobeNewswire
Aerovate Therapeutics Target of Unusually Large Options Trading (NASDAQ:AVTE) - MarketBeat
Jane Street Group LLC Trims Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Jane Street Group LLC Trims Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Increases By 35.5% - MarketBeat
Unusually active option classes on open January 16th - TipRanks
Geode Capital Management LLC Sells 25,287 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Barclays PLC Has $39,000 Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
State Street Corp Raises Stock Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders - The Eastern Progress Online
Fmr LLC Boosts Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Charles Schwab Investment Management Inc. Reduces Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerAVTE, BCOV, ALVR, AE - cnhinews.com
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - Defense World
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 5.3% in November - MarketBeat
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - The Eastern Progress Online
Verition Fund Management LLC Sells 149,137 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Pulmonary Arterial Hypertension Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen Pharma, Aerovate - The Globe and Mail
Aerovate Therapeutics Inc Stock (AVTE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):